We have previously show" thai after peripheral nerve lesion the synthesis 0' NGF is induced in cells 01 the nerve sheath (Heumann el 81., 19878). Further analysis led 10 the identiflcation 01 growth factars and intracellular mechanisms responsible 10r this induction in sciatic fibroblasts (lind holm el 81., 1988; Hengerer el 81., 1990). The prese"t work aimed al the elucidation of the regulation 0' NGF synthesis in Schwan" cells.
Schwann cell s are the glial cclls of the PNS. They play an essential role in the formation of the microenvi ronment of the neuro nal axons. Dependi ng on thc propcrt ics ofthe axons, thcy form myelin sheaths or ensheath the axons in nonm yel inated form (Wei nbergand Spencer, 1975; Aguayo ct al. , 1976) . Bcsides myclin prote ins, Schwann cells synthesize componcnts of the ex tracellu lar matrix (ßungcct al. , 1980; Carey et al. , 1983; Combrooks ct al. , 198J; McGarvey et aL, 1984; Mehta Cl al. , 1985) , cell adhesion molecules (Nicke and Schachner, 1985: Noble cl al. , 1985 ; Dan i10ff et al. , 1986) , and also neurolrophie faetors such as NGF (Riehardson and Ebenda l, 1982; Ru sh, 1984; Assou line el al., 1987; ßand tlow ct al., 1987) . In the adult sciatic nerve, the eontribution of the non-neuronal cells to th e NGF supply for the NGF-depcndent (sympalhetiea nd subsets ofneural erest-derived sensory; for review, see Levi-Monta lcini and Angeleui, 1968; Thocncn and Barde, 1980) neurons is negligi ble (Heu ma nn Cl al. , 1987a) . These neurons are troph icall y supponed from their pcripheral target tissues. However, after nerve lesion there is a massive increase in the synthesis of NGF by thc scia tie non-neuronal cell s (Heumann el al., 1987a.b) . ln situ hybridization experiments demonstrated that all the non-neuronal cell s in the lesioncd seia lic nerve, in panicular Schwann cells and fibroblasts, express NGF-mRNA (Bandl10w el al., 198 7; Heumann el al. , 1987a) . This 1csion-medialcd induetion ofN GFmRNA in the sciatic nerve occurs in a biphasic manner (Heumann ct al. , 1987a) . T he secend prolonged incrcasc is eorrclated wi th the immigration of macrophages. A causal rclationship bctwccn these two phenomena eould be deduced from the fac t that in explants of sciatie nerve only the in itial and not the sceond prolonged inereasc in NGF-mRNA could be observed. However, the biphasic in vivo situation could be mimicktd by the addition ofaclivated maerophages (Heu man n et al. , 1987b) , and in terleukin-I (lL-I) was identified as a mediator of this prolonged elevati on of NGF-mRNA (Lindholm et al. , 1987) . In fu n her experiments, it has bcen demonstratcd that fibroblasts, di ssociated from adult rat sciatic nerve, also respond to IL-I by an inereasc in NGF-mRNA (Lindholm et al. , 1988) . Howeve r, it was not c1ear whether NGF synthesis in Schwann cells, wh ich represent thc most abundant cell type of the scia tie nerve, is rcgulatcd in a si mila r manner.
In the present experiments, we ana1yzed in Schwann eell cullure the effects cf those faeters and cytokines that have prcviousl)' bcen s hown to incrcase NGF-mRNA in othcr cell types, particularly in fibroblasts and astrocytes. Moreover, we investigalcd thc e lreet ofSch wa nn cell-axon interactions a nd fina ll y second messenger systems that could bc in volvcd in thc regulation of NG F-mRN A synthcsis in Schwann cclls. We repon that none of the growth factors and cYlokines tcstcd incrcased NGF-mR NA levels in Schwann cells; ho wever, forskolin (FK; an aetivalor ofad enylate cyclase), cAMP derivatives, and agonists of .6-adrenergie reeeplors produccd a markcd incrcasc in NGF-mRNA levels in Schwann eells. Transforminggrowth factor ß -I (T GF-ß I), the most powerful inducer of NGF-mRNA in astrocylc culturcs (Lindholm CI al. , 1990) , not only did n ot inercasc the NGF-mRNA levels in Schwa nn eells, but even redueed the basal level and abolished the inercase initiated by FK in Schwann eells.
Materials and Methods
Ma/erial5. Dulbecco's modificd Eagle's medium (DMEM ), Ham's FI2 mediu m, Minima[ Essentia[ Medium (MEM) , penicillin, streptomycin, poIY-L-lysine, eytosine.ß-D-arabinofuranosidc (Ara-C), mouse epidermal growth faetor (EGF). (± )-norepinephrine, ( -)-isoprotcrenol. {± }-metoprolol, clonidin, prostagla ndi n E:, fONkolin (7ß-aceloxy-8, 13-cpoxy-Ia ,6ß.9a-trihydroxylabd-14-cne-II-one). ionomyein, phorbol 12-myristate 13-acetate (TPA), eyclo hexi mide, aetinomycin D, , N"-be nzoyl-cAMP, and rat calcitoni n gene-related peptide (CG RP) were purchased from Sigma (St. Louis). Human platelet~eri vedgrowth faetor AB (PDGF-AB), poreine PDGF-BB. and TGF-,6 1 were pureh ased from British BiO-lcchnology (Qxford), fetal calf serum (FCS) was from Boehringer Mannheim (Mannheim), 1-(5-isoquinoli nesulfonyl)-2 -mClhylpiperazine di hydrochloride (H-7) and N-[2-(mcthylamino )ethy [l-5- isoquinoline sul fonamide dihydrochloride (H -8) wert from Scikagaku Kogyo (Tokyo), and EHS [aminin was from GIB-CO-BRL (Eggenstein, Gennany). We gt3lelil!ly acknowlcdge the generous gifls of the following materials: human rccombina nt IL-I(j and IL-Ia (Biogen, Geneva) by councsy ofDrs. A. Gronenbom (Max Planek Institu te for BiochemiSlry, Maninsreid) and P. WingJ1e[d (Biogen, Geneva) , bovine reeombinant basic fibroblast growt h faetOT (bFGF) (Progen. Heidelt)Crg) by eoun esy ofDr W. Risau (Max Planek Institute for Psyehiatry), human recombinant insulin-like groWlh factors land 11 (IGF-I and IGF-II) from Dr. A. Skottner of Kabi Peptide Hormone (Stockholm), and the gangl ioside mixture (composition: GMI :GD la: GDlb: , originall y prepa red by Fidia, ltaly, from Drs. Y. Arakawa and H. Qz.awa of Eisai Phannaceuticals Co. Ltd. (Tokyo) . NGF purified from mouse submandibularg.!and (for rtference, see Saada t el al., 1989), bra in~eri ved neurotrophic faetor (B DNF) purirte<! from pig brain (Hofer and Barde, 1988) , and eiliary neurot rophic faeloT (CNTF) purified from rat sciatic nerves (Saadat ct al., 1989 ) werc provided by Drs. H. Rohrer, Y._A. Barde, and M. Sendiner, respeclively, from our laboratory. Batehes of protein factors from commereial sources used in this stud y have shown biologic'al activity in other systems (for IL-Ia, IL-I ß. EGF, b FGF, POGF: Spranger et al., 1990 ; for IGF-I and IGF-I1: Arakawa ct al., 1990) . Ncurotrophic factors purified in the laboratory (NGF, ßDNF, CNTF) were full y aetive in the appropriate biousay. All the other ehemicals were of reagent grade.
Cell umJ "'gun ,·ultuTe. SdlW .. "" u:lIs wen: pl cpared by a modif'C3lion of published met hods (Poner et al., 1986) . Scialic nerves were dissected from 2-]-d-old Wistar ra ts and treated with 0.1% collagenase (S igma) in Ca" _Mg1+ _frec POS for 40 min and funher ineubatc:d with 0. 1"-trypsin for 20 min . After trit uration with a Pasteur pipclte, dissociated cells wcre plated on 6 em dishes in DMEM supplernented with 10% FCS (10% FCSlDMEM) and antibiotics (100 Utml penieillin and 0.1 mg/mI streptomycin). Cclls were exposed to two cycles of Ara-C treatment ( 10 }'M) for 3 d eaeh to eliminalc proliferaring fibroblasts. After 7 d , cells were washed, split, and plated on poIY-L-lysinc-coated 6 cm dishes in 10% FCSlDMEM containing IO},M FK and antibiotics. The cells were cultured for a maxim um of 8 d in the pTe5ence of FK. Qnce conftuenl, medi um was ehanged to 10% FCS/ DMEM eontaining antibiotics followed by the same medium change evcry third day. Expanded Schwann cells wert! subculturetl uncc mon;: fOI' cxpt:rimcnts aRel at least 1 wee k without FK. Purity ofSchwann cells was higher than 98% when evaluated by immunostaining for NGF receplor (Chandler et al., 1984) [antibody Mel92 ... as a gcnl'rous giR ofOn. E. Shooter (S tanford University) and M. Hosang(Hoffman-LaRoche, Basel)1 and S-IOO protein, ... hich in the PNS is a spc:cific marker for Schwann alls (Slcfansson CI at., 1982) 
Ad ult rat sciatic fibroblasts and ex pla nt cultures of ra t sciatic nerve segments were prcparcd as described by Lindholm et at. (1988) and Heumann el al. (I 987b) , resJ)CCtively.
Thc medium used for stim ulation of cells and nerve segments was 10% FCS/ DMEM un iess otherwise stated. Wherc specilied, 1% FCS/ DMEM or a serum-free medium consisting oCa I: I mix ture of Ha m's FI2 medium and MEM containing a modified N: supplement (eontai nins 30 nM se[enium, [00 11M putrescine, 5 lIg/ml insulin, and I mg/ ml transfemn, but no progesterone) was used (Bottenstei n and Sato, 1979) .
Sympathetic neurons were obtained from superio r cervieal ganglia of newbom rats and cultured in serum-free mediu m (see Saadal et al.. 1989) .
RNA puparalion and Nor/hun bio/ analysis. Total RNA was prepared from cells and tissue that had been kept frolen after stim ulation aceording 10 the method of Chomczynski and Saeehi ( 1987) . The u traetion buffer oontaincd 20 PS of a O,!5I -ldlobase (Kb)-I<mg NGF standard RNA to evaluate thc recovcry of mRNA. Total RNA sampies and different amounts offull-[ength NGF-mRNA standard were g1yoxy[ated, e1ect rophoresed through a 1.5% agarose ge l, and thcn transferred to a nylon membrane (Hybond-N, Amersham). Following transfer, membranes were fixed by UV irradiation, prchybridized, and hybridized with " P-Ia beled NGF-cRNA probc(O. 92 Kb)at 68"C in 50% fonnamide (see He umann el al., 1987a) . The membranes were washed and exposed to Fuji RX films al -80"(: for 12-]6 hr. The amounl ofccllular NGFmRNA present was quan tified by densilomelric scanning (LKB UIlrosean XL) ofthe autoradiograms and correcti on for RNA recovery.
NGF ELISA. Thc amount of NGF in the medium ofSchwann teils was measurcd by a sensitive two-site ELiSA (Korsching and Thoc:nen, 1983 ) with recentl y describcd modifications (Spranger et al., 1990 ± 2.30 (f! = 35) and 2.00 ± 0.99 (n = 7) pg of NGF-mRNN 1()6 cen s, respe<:tively. Addition of 10% FeS 10 Schwann eells kepl in serum-free medium led 10 a gradual inerca se in NGFmRNA levels that d id not becomc appa rent before at least 24 hr after m edium change. This is in contrast to Ihe rapid and m assive response of astrocytes to serum (Sprangcr CI al., 1990) . Since the present stud y was initiated by the prcviously observed more than lO-fold increase in NGF-mRNA levels after lesion of t he sciat ie nerve, we focuscd our a ttentio n o n eh a nges in NGF-mR NA levels o f more than twofold .
IL-I has been shown to increase NG F-mRNA levels in a variet y of system s, including explan t e ulture of seiatie nerve Sl.""gIllCll ts, f,brob1ast:; i~v[a too frV III st:"ial i~, astnx;ytt:1S in culturc , and h ip pocampus in vi\'Q (Lindholm CI a\., 198 7, 1988; Spranger et al., 1990) . PDGF has a lso been sh own to increase NGFmRNA levels in cxplant cullures of seiat ie nerve segmen ts (Lind holm el al., 1987) . EGF and bFG Fwerc shown toaugme nt NGF-m RNA levels in cultured astrocytes (Spranger el al.. 1990 ). Thereforc, Schwann cells werc treated with growth factors and cytokines including PDGF (Aß and 88), EGF, bFGF. IGF-I , IGF-II, and 1L-1.6 fo r 3--6 hr, either individually in thc p rcscnce of various serum eoncentrations (1 0%, 1%, o r serum-frcc) or after prctreatmcnt with FK (24--48 hr). None o fthese conditions revealed an influencc ofgrowth factors or cytokines o n the NGFmRNA levels in Schwann eells (for ineubation with in d ividual factoTS, see T able 1). I L-I a a lso had no elTecL In addition, we Schwann teils (0.4-0.6 .. 10" cclb) weil: trcated wi tl! ractors in strum-frtt medium (EGF l nd bFGF) or 10'Ii0 FCSI DMEM medium (rest of the faclors) for the indicated time befoll: euraclion. The dall Ire Ille mean of duplicate dttenninations unless indiClled otncrwist .
• SinaJe dettnnination .
• Mcall ;t SO (11 -S).
tested ncurotrophic proteins, whieh are synthesized in thc sciatie or by Schwann ceHs. Howcver, the addition of NGF, BDNF, and CNTF had no essential efTects on the NGF-mRNA content (Table I ). The effcct ofTGF-,8 1 is described separately.
t::o"ec( 0/ axonal conlac(
Jn the adu ll animal , Schwann eells exist in close axonal eontact.
To study the influence ofaxonal contaet, we analyzed a neuronSchwann eel l eoculture system. Pure cultures of superiorccrv ieal ganglionic neurons from ncwbom rals, wh ich in the presenee of NGF extcnded a rieh neurite network on lami nin, were replenished with pure Schwann eells. Nearly all Schwann ccJ1s established eontact with axons and maintained eontaet for the entire euhure period ( Gangliosides have bccn reportcd to increasc steady state NGF levels in culture medium ofSchwann eells (Ohi et al. , 1990) . fn our experiments, a mil'.ture of gangliosides obtai ned from the same sou rce and applied at I mM (average concentration) for 3-24 hr toSchwann cells eulturcs did not result in any significant inerease in NGF-mRNA levels (dat3 not shown).
Regulation o/rhe NGF-mRNA level in Schwann cells by cAMP /:..1[ecl 0/ FK. cAMP analogs. and ,8-adrenergic receplor agonislS.
Treatment ofSchwann cells cultivated in 10% FCSlDMEM with FK, 3 reversible activator oradenylate cyclase. for 6 hr resultcd in a six-to eightfold inerease in NGF-mRNA levels, irrespeetive of the prcscncc of I L-l ,8 ( Fig. 2 . upper lanes). In serum-free medium , although the basal levels of NGF-mRNA are decrcased, FK sti ll exerted a 2.7-fold induction of NGF-mRNA (Fig. 2 , lower lanes). Treatment of Schwann eells with 8-8r-cAMP and N'-benzoyl-cAMP, membrane-permeable analogs of cAMP, also inereascd the NGF-mRNA (Fig. 3A) . The order of poteney of cAMP analogs (i.e., JVt>-benzoyl-cAM P > 8-Br-cAM P) was in aecordanee with other eAMP-dependent systems such as lipolysis in adipocytes (Beebe et al., 1984) . Dideoxyforskolin . a FK analog that possesses most ofthe cAMP-independent effeets of FK but lacks the ability to activate adenylate cyclase (see Lauren"l3 et al., 1989) , did 'not increasc NGF-mRNA levels (Fig. 3A) . The incffcctiveness of 8-bromo-cGMP (8-Br-cGMP) indieatcs that activation of guanylate eyclase does not playa role in induetion ofNGF-mRNA.
Norepi neprine and isoproterenol. ß-adrenergic receptor agonists already shown to inerease eAMP leve)s in Schwann cells (Yasuda et al. , J 988) , also incrcased NGF-mRNA to levels similar to those aehieved by FK treatment (Fig. 38) . In contrast, clonidin, an lr-adrenergic receptor agonist that docs not affcct cAMP levels, did not change thc NGF-mRNA content . The induetlon of NGF-mRNA by norepincphrine was abolishcd by meloprolol, a specific ß, -adrenergje rcceptor antagonist (Fig.  3B) . CGRP, which has been reported 10 increase cA MP in other cell types (Laufer and Changeux, 1987; villar et al., 1989) , did notgivesignifIcantchanges in the NGF-mRNA levels in Schwann eells (1.3-fold incrcasc for CG RP).
Primary Schwan n cells that were prepared from newbom rat sciatic nerve and Ara-C treated as described but without expansion by FK also responded 10 FK by an incrcase in NGFmRNA levels eomparable to expanded cultures. Again , they did not respond to IL-I (data not shown). Thisobservation indieatcs that FK administered in order to achieve the large cell numbers nccessary for the Northem blot experiments does not pcrmanently change Ihe regulation ofNGF synthesis in Schwann cells. The concentration dependence ofthe FK induction ofNGFmRNA in Schwann cells was measured. As shown in Figure 4A , NGF-mRNA in serum-containingmcdium was maximally(8.3-fold) induced by 30 J.lM FK, and the half-maximal concentration was approximately 6 ~M. These values are in the same range as those reported for the elevation of intracellular cAMP by FK (Scamon and Daly, 1981) . The concentration dependence of NGF-mRNA induclion by FK in serum-free medium was similar to that in serum-containing medium (data not shown).
Analysis ofthe time course ofthe FK cffect on NGF-mRNA ( Fig. 48) showed that the level of NGF-mRNA increased drastically bctwecn land 3 hr after thc addition of I 0 ~M FK, reached a plateau bctween 3 and 6 hr, and thereafter gradually decreased 10 less than twofold at 24 hr (Fig. 4B) . The level ofNGF-mRNA 48 hr after addition of FK was almost equal to thc basallevcl before cxposurc to FK. Induction of NGF-mRNA by 0.1 mM isoproterenol showed kinetics similar to that of FK, reaching its maximum at 3 hr (Fig. 4B) . However, the level of NGFmRNA retumed 10 the basal level 6 hr after addition of isoproterenol. This cffcct may bc due to thc desensitization ofthe ß -adrencrgic receptor.
Modification olthe FX ejJeet by ionomycin and TPA. Treatment ofSchwann cells for 3 hr with I ~glml ionomycin, a Ca 2 + ionophore, slightly incrcased the NGF-mRNA level (twofold from the basal level; Fig. 5A,B) . However, when ionomycin was added together with FK at 20 J.lM , wherc the FK effect itselfwas almost maximal (see Fig. 4A ), the NGF-mRNA level in Schwann cells increased markedly to 15-fold the basal level (approximately twofold the level increased by FK alone; Fig. 5A,B) . This elfect of ionomycin was abolished by 5 mM EDT A, a chelator of divalent cations (data not shown). Application of ionomycin together with either 0.1 mM norepinephrine or 0.1 mM isoproterenol again resulted in a synergistic increase of the NGFmRNA, reachinga level12-fold higher than the basal level (data not shown).
TPA, a phorbol ester and potent activator of protein kinase (PKC), exerted opposite effects on the basal as comparcd to FKinduced levels of NGF-mRNA in Schwann cells. Treatment of Schwann cells with 0.1 ~g1ml TPA for 3 hr significantly reduced the basal level of NGF-mRNA (to approximately 30% of the basal level), while treatment with TPA in the presence of FK remarkably increased the NGF-mRNA to a level (approximatdy 13-15-fold of basal level) similar 10 the level induccd by combination of ionomycin and FK (Fig. SA,B) . Treatment ofSchwann cells with ionomycin, TPA, and FK all at one time elevated the level ofNGF-mRNA slightly more than either of the combinations ionomycin and FK or TPA and FK.
Ejfects o!inhibitors o!proteinphosphorylation.ln mammalian systems, most ofthe elfects of elevated cAMP on cellular events are shown to bc mediated by activation of cAMP-dependent protein kinasc (PKA) (Edelman et al. , 1987) . Therefore. we investigated the putative role ofprotein phosphorylation in the regulation of NGF gene expression using the protein kinase inhibitors H-7 and H-8. In a cell-free system, H-7 was shown to bc selective for PKC(K, = 6.0 ~M), while H-8 is moreselective for PKA (X, = 1.2 ~M) than fOT PKC (Xi = IS J.lM) (Hidaka et al., 1989) . As shown in Figure 5B . pretreatment of Schwann cells with H-7 up to 50 J.lM did not reduce the levels ofNGF· mRNA in most ofthe conditions used. However, the effect of a combination ofTPAand FK was reduccd by 50 ~M H-7 dose to that achieved by FK alone, suggesting a role ofPKC activation in the enhancement ofFK action. On thc olher hand, pretreatment ofSchwann cells with 50 J.lM H-8 drastically reduced the NGF-mRNA levels under all experimental conditions tested (Fig. SB) . Thus, H-8 suppressed not only the elfect of FK, but also the potentiating elfects ofTPA and ionomycin. It also reduced thc basal NGF-mRNA levels to nearly undetectable values.
EjJects 01 cycloheximide. Cycloheximide, an inhibitor ofprotein synthesis, is known to affect the levels of various mRNAs by eliminating short-lived proteins responsible for either transcriptional repression or destabilization ofmRNAs (Shaw and Kamen, 1986) . As shown in Figure 6 , incubation ofSchwann cells with 10 ~glml cycloheximide for 3 hr resulted in an increase in NGF-mRNA levels comparable to the level measured after FK treatment. Concomitant application of cycloheximide and FK to Schwann cells resulted in an additive elfect on NGFmRNA levels, suggesting that synthesis oftranscriptional activators is not required for the action of FK.
Stability 01 the NGF-mRNA in Schwann cells. The half-life ofNGF-mRNA was measured by following the time course of the decay ofNGF-mRNA after the addition ofactinomycin D. a transcriptional inhibitor, to cells stimulated with FK. ionomycin, or cycloheximide (Fig. 7) . The results are summarized in Table 2 . NGF-mRNA in Schwann cells without stimulation + + had a half-life (I"') ofO.67 hr. Cycloheximide clearly prolonged the half-li fe 3A-fold, suggesting that at least part ofits effect is on the stabilization of NGF-mRNA. On thc other hand, FK, which increased the NGF-mRNA content 10 higher levels than cyclohcximide, did not significantly prolong the half-life ofNGFmRNA. lonomycin, which increased the steady state NGFmRNA level about twofold, also failed 10 prolong the lifetime, 
Effect o/ TGF-ß I on NGF-mRNA levels in Schwann cells
It has recently been reported that TGF-ß I and TGF-ß2 are milogcnic for rat sciatic Schwann cells and aet synergistically with FK on the proliferation ofthese cells (Eccleston et al. , Values a~ ealculated from the experimenu oF FigUR 7 .
• Relative to h.alf-life detennined fOT nontrea!ed cells . Ridley et al., 1989) . Funhennore, TGF-ß I increascd the NGFmRNA levels in astrocytes in culture 50-fold . These observations prompled us 10 examine Ihe effecl ofTGF-,B 1 on Ihe level ofNGF-mRNA in Schwann cells in the presence and a bsence of FK. As shown in Figure 2 , treatment o f Schwann cells with TUF-.B I (2 nglml) decrcased the NUFmRNA levels hath in the presence and absence o f serum. As A 10
. shown in Figure 8A . Ihe basal level of NGF-mRNA staned tO decrease between 3-6 hr after addition ofTGF-,B I. We analyzed the minimal time of pretrealment necessary for the effec! of TGF-ß. When Schwann cells we re pretreated with TGF-ß I for various periods beforc addition of FK for another 3 hr, a significant inhibitio n ofTGF-,81 on the FK-induced NGF-mRNA became det«:table with pretreatment periods longer than 6 hr (Fig. 8B) . When TG F-,B I was added simultaneously with FK, the inhibitory effect of T GF-,81 stancd after 6 hr (data not shown). The effee! ofTGF-,8 l was transient, since it was not obscrved after 24 hr pretreatmen t (Fig. 8B) . The effect ofTGF-PI was maximal at 2 nglml ( 
Effeci o[ FK, iOllomydn. and TGF-ßI on the concentration 0/ NGF protein in the medium 0/ Schwann cell cultures
NG F protein accumulating in the culture medium during 24 hr incubation with FK, ionomycin, and T GF-ßl was measurcd by a two-site ELiSA (Fig. 9) . FK increased the NG F concentration 1.7-fold. Concomitant apptication ofFK and ionomycin showed a remarkable increase in the NGFconcentration (4.6-fold). TGFßl (4 nglml), addcd logcthcr with FK,abolishcd the FK-ind uced increase in NGF protein in agreement with the effect ofTGF-ß1 on the NGF-mRNA as describcd above. TGF-ß I added alone also gave a small decrease in basal NG F concentration.
Our intention was to demonstrate that the changes of NGFmRNA levels are paralleled by ehanges in the amount ofsccreted protein. T herefore, we did not attem pt to optimize the recovery ofNG F protein from Schwann cell conditioned medium by the indusion of protease inhibi tors.
Comparison ofthe effects of FK and IL-J on the NGF-mRNA levels in nerve organ culrure and sciatic fibroblasls
To assess the question whether FK also acts in the complex, nondissociated tissue, we performed experiments on ncwbom and adult rat sciatic nerve organ cult ure and fLbro blasts prepared from adult rat sciatie. As shown in Figure IOA , treatment of explant culture of newbom rat seiatie nerve segments (a nimals were ofthe same age as those used for Schwann cell preparation) wi th IL-1ß for 3 hr increased NGF-mRNA eightfold . FK at 20 ~M also inereased the NGF-m RNA signiftcantly(fivefold). lonom yein, whieh itsclfhad no effcct, enhanced the response to FK inereasing the NGF-mRNA levels seven fo ld.lonomycin did not furt her elevate the IL-Iß-med iated increase in NGF-mR NA levels (data not shown). In adult sciatic nerve explant culture, 20 ~M FK had an efficacy almost CQ uivalent to that of IL-Iß (Fig. J 08) . lonomycin did not furthcren hance the effcct ofeithcr IL-Iß or FK. In eultures offibroblasts prepared from adult rat sciatic nerves, FK was less effective than IL-lß (Fig. lOG) .
Discussion
A major concern regarding the in vilro approach chosen in this study may be its relevance for the in vivo sit uation. Schwann Porter et al., 1986; Ru tkowski et a1., 1990) . Particularly, the effects of the comlXJunds used for cell seleetion and induelion ofSchwann cell proliferation are reversible. T his interpretation is supported by our observation that the expansion of the Schwann cell cultures by FK did not change the regulation of NGF-mRNA. Furthermore, the regulation by cAMP was largely independent ofthe cell environmentand wasdetected in purified cultures as weil as in nondissociated nerve segments and Schwann ccll-ncuron eoeulture. Si nce for teehnical reasons large n umbers ofSchwann cells eould only be obtaincd from newbom animals, we also analyzed the response to IL-l and FK of newbom in eomparison to adult nerve organ culture. No age-depcndc nt differences in NGF-m RNA regulation were detectable. In the following, we d iscuss the main eharaeteristics of NG F regulation in Sehwann ccHs, that is, the ineffcctiveness ofgrowth factors to increasc NGF-mRNA levels and possiblc molccular mcchanisms responsible for the regulation by cAM P; moreover, wc em phasize the striking differences bctween the NGF regulation in Schwann eells and that in various other ccll types.
Regulation by growth faclors
The available data show that IL-I is a potent regulator ofNGFmRNA expression in sciatic nerve and fI broblasts (Lindholm et al., 1987 (Lindholm et al., , 1988 . IL-I has also becn shown to increase NGFmRNA in cclls and tissues of the CNS, that is, in eullured astrocytes and in thc hippocam pus after inlravcntricular injcctio n (S pranger el al., 1990). The inability of Schwann cells to res pond 10 IL-I does not seem to be duc to lack oflL-1 receptors, since by using iodinated IL-I we found spccifie IL-I binding sites on Schwann cells with an affmily constant comparable 10 that described fo r typical IL-I responding cells (M. Meyer and H. Thoenen, unpublished observations). Furtherrnare, prelim-
. . inary quantiflcation of IL-I bioactivity in Schwann cell conditioned medium gave no indication ofautocrine IL-l production, which could result either in saluration of the IL-I response or in descnsitization. This suggests that the Schwann cell IL-I receplor, in contrast to its counterpart on astrocytes and fibroblasls, is funclionall y uncoupted from intracellular meehanisms of NGF regulation. OUT Schwann cell-neuron coculture experiments show that coupling does not simply dcpend on axonal contaet, although it may be argued that OUT culture conditions did not warrant an ill ~'ivo type of contacl. We cannot exc1ude that culture conditions thai promote extensive enshealhment and basal lamina formation (Bunge CI al., 1986) would givc different results. OUf experiments revealed a similar situation for POGF and bFGF. In Schwalm cells, these growth factors regulatc cell proliferation and c-fos mRNA levels (Ramer et al., 1988; Davis and Stroobant, 1989; Weinmaster and L.emke, 1990) , but, again in contrasilo astrocytes (Spranger CI al., 1990) , Ihey have nocffcct on Ihc levclsofNGF-mRNA. Sincc Schwann cells possess Ihe low-affinilY NGF rcceptor (DiStefano and Johnson, 1988; Yasuda el al. , 1987) , wc tesled Ihc possibililY of a feedback controt. However, addition neither orNGF nor ofthe structurally rclated ßONF (Leibrock el al., 1989) rcsulted in any significanlchangeofNGF-mRNA levels. Also, CNTF, which is produced by Schwann cells in thc intact scia lic nerve (Lin cl al., 1989; Stöckli cl al. , 1989) , did not significantly change NGFmRNA levels. describcd in endothclial cell culturc, whcrc thc cffccts of bFGF werc suppressed by TGF-ß (Saksela CI al., 1987) . Thc moleculn basis for these diffcrcnccs in NGF-mRNA regulation between astrocytes and Schwan n cells remains to be cl ucidated. Cisacting seQuences mediating transcriptional repression by TGF-ß have been identified in the promoter of the transin gene (Kcrr et aJ. , 1990) ; however, difterences in the trans-acting factors wo uld have to account for cell type specificity.
Mechanism ojregulalion by adenylale cyclase
As a second approach for analyzing NGF regulation in Schwann cells, we analyzed the involvement ofsecond messengers. Using different analogs of FK and cAMP, we have shown that the major signal transduction pathway leading to an increase in NGF-mRNA levels in Schwann cells involves activation ofadenylate cyclase, whereas PKC activation resulted in decreased NG F-m RNA levels. This is in contrast to the situation described for fibroblasts (\Vion et al., 1990) . Activation of adenylate cyclase via the ß, -adrenergic receptor also resulted in augmentcd NG F-mRNA kvt:ls. Th isadcnylat ccyda s{.~cpcndcnl pathway is not specifie forSehwann cells; small increases in NGF-m R NA occurring after adenylate eyc1ase activation have also bcen demonstrated in rat primary astrocytes (Schwartz and Mishler, 1990) , in glioma cells (Dal Toso et al., 1988; Sehwartz, 1988) , and in the present study in fibroblasts derived from the seiatic. AIthough protein kinase inhibitors are not absol utely selective for spcciflC kinases, considering the exc1usive effectiveness of H·g we propose protein kinase A activation as the next step of the signal ing pathway. FK inereases the NGF-mRNA levels in Schwann cclls with kinctics comparablc 10 Ihose in systems wherc a rclationship bctwccn transcriptional activation by cAM P and increase in steady state m RN A is established (e.g., Sasaki et al., 1984; Schmid et a1. , 1987) . In agreemen t with the assum ption oftranseriptional activation ofthe NGF gene by FK, we did not observe any major infl uence of FK on NGF-mRNA stability. Preliminary transfeetion experiments using NG F-promoter/chloramphenicol acetyl transferase (CAT) construets showed that CAT activity is inducib1e by FK , conflrming its action at the transcriptional level (I. Matsuoka, M. Meyer, and H. Thoenen, unpublished observations). lt will be interesting to see whether a typical cAMP response element (CRE), for examp1e, as describcd for the somatostatin gene promoter (for review, see Montminy et aJ. , 1990) or a different sequence, is involved. A multiplicity of trans-acting factors involycd m eAM P-mediatcd transcriptional activation have been identified (for an overview, see f-I abcner, 1990; Ziff, 1990) . Although cAMP seems to bc an essential faetor regulating NGF expression in Schwann cells, the modulatory effects of Cal~ ionophore and phorbol ester point to a eomplell regulatiorl. It should again be stressed that the potentiating effects ofthese drugs were H-8 sensitive and dependent on adenylatc cyclase activation. The molecular basis fo r these observations may bc found either in posttranslational modifieations of Irans-acting factors (Gonzalez et al., 1989; Sheng et al., 1990; Van Nguyen et al. , 1990) or by effects on upstream elements of the signaling pathway, sueh as modifIeation oradenylate cyclase acüvity (SU3-den et al., 1985; Rozengurt et al., 1987; Yoshimasa et al., I 98'i) .
Observations made in fibroblasts and glioma cel ls suggest that synthesis of the immediate early gene product, e-Fos proteirl, plays an important role in the regulation ofNGF-mRNA (Mo :-eheUI et al., 1989; Hengerer et al., 1990) . The c-Fos-dependerlt transactivat ion of the NG F gene in fibroblasts is mediated via an a ctivator protein I (A P-I) site located in the first intron of thc NGF gene (Hcngcrcr ct al. , 1990) . Howevcr, in Schwann teils the rc latio nship between the expression of c-Fos protein und NCF is no t establi shed. Conditions thut lead 10 high levels ofexpression ofe-fos mR NA and Ap·l binding activity (c.g., TPA o r serum addition; M. Meyer, I. Matsuoko, and H. Thoenen . unpublished observations) in Schwann cells da not rcsult in increased NGF-mRNA expressio n (see Results). These observatio ns may suggest that functional AP-l complex formed in Schwa nn cclls after the appropriate stimulation can not, in contrast to fibro blasts , interact with the intronie AP-l site of the NGF gene and/or o the r components of the transcription apparatus in a way necessary for transcriptional activation of the NGF gene. In contrast to astrocylcs and fibroblasts, whcrc cyclohex im ide had an inhibitoryeffect on the induction ofNGFmRNA (Moccheui et al. , [989; Hengereret al. , 1990 ; Lindholm e t a l. , 1990; Wion et ar., 1990), cycloheximide addcd I08elher with FK incrl;ased the NGF+mR NA level in an additive manner in Schwann ~e ll s. This resull suggests that de nOI'O synthesis of t ranscriptic-nal activalors is not neccssary for the elfect of FK, whie h is consiste nt with the idea that posttranslational modifieation of p rccxisting C RE· binding facto rs might bc involved (sec reviews; Yamamoto et al., 1988) . In contrast, transacti· vation o f genes via A P·I depends on de no ro c-Fos protein synthcsis (Schönthai ct at. , 1988).
Regulation of intrace llular cAMP levels has bcen shown, at least in \'itro, to bc importanl for Sehwann cell prOliferation and diffe rentiation (Raffet al., 1978; see, e.g., Sobue and Pleasure, 1984; Monuki c t aL, 1989 ). It is not c1car which additional factors are n eeded to drive the eel1s in one dircction or the other. The regulation of NGF-mRNA by cAMP elevation seems 10 be more or less independent or additional factors since it required o nl y a very simple c ulture medium, Furthermore, it is interesting to note that cAM P increases NGF-mRNA transientIy, whereas ils e ffccts on markers of differentiation, such as galactoccrebroside and myelin gene induction, are observed for exlended perioos after t re atme nt (Sobue and Pleasure, 1984; Monuki c t a l., 1989) . It is not c1car whether increases in cAMP conte nt ofSchwann cdls occu r also in ~'ivo. and moleeules rcsponsi ble re main 10 bc identified . Neurotransmitters and neuropeptides acting on rcc:cptors coupled to adenylate cyc1asc are candidates, buttheir accumulation to cffective extracellular concentrations after nerve lesion has to bc demonstrated. The presence ofCGRP has bccn demonstrated in spinal motoncurons and d o rsal root ganglion neurons (Rosenfeld et aL, 1983; Gibson CI al., 1984; Fontai ne el a1. , 1986; New and Mudge, 198 6; Villar et a l. , 1989) . It is not known at present whether Schwann cells respond to CGRP by elevation of cAM P as has bcen demonstrated for m yot ubcs (Laufer and C hangeux, 1987; Villar el al., 1989) . In conc1usion , a wide variety ofdifferent cell types, inc1uding several types ofglial cells and neurons (for rcfercnces, see Zafra et 011. , t990) , can e Apress NGF. Together with prcvious invcst iga tions, we have shown he re that evcn in one tissue. namely the sciatic nc rve, different non-neuronal cell types show a surp ri sing multiplic ily of mec hanisms of NGF regulation . To bc able to explo il the POtential therapeutical value ofsuch studics, Ihe molec ular basis fo r these differences has 10 bc worked out.
